| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Oettel M et al. | STS 557 as an interceptive in rodents and baboons. | 1980 | Contraception | pmid:7428362 |
| Kasid A et al. | Interaction of progestins with steroid receptors in human uterus. | 1978 | Biochem. J. | pmid:743257 |
| Moretti G et al. | [Transitory ischemic attacks, migraine and progestogen drugs. Etiopathogenetic correlations]. | 1980 | Minerva Med. | pmid:7432644 |
| Chowdhury V et al. | 'Escape' ovulation in women due to the missing of low dose combination oral contraceptive pills. | 1980 | Contraception | pmid:7438752 |
| DÃaz S et al. | Ectopic pregnancies associated with low dose progestagen-releasing IUDs. | 1980 | Contraception | pmid:7438753 |
| Benagiano G et al. | Return of ovarian function and endometrial morphology in women treated with norethisterone oenanthate: a pilot study. | 1980 | Fertil. Steril. | pmid:7439410 |
| Lewis CJ et al. | Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin. | 1980 | Xenobiotica | pmid:7445531 |
| Virutamasen P et al. | A clinical and metabolic study of norethisterone oenanthate in Thai women. | 1980 | Contraception | pmid:7449388 |
| Lai JC et al. | The activity of glucose-6-phosphate dehydrogenase in liver and hypothalamus of the female rat: effects of administration of ethinyloestradiol and the progestogens norethisterone acetate and d-norgestrel. | 1980 | Biochem. Soc. Trans. | pmid:7450248 |
| Leung TK et al. | The activities of the A and B forms of monoamine oxidase in liver, hypothalamus and cerebral cortex of the female rat: effects of administration of ethinyloestradiol and the progestogens norethisterone acetate and d-norgestrel. | 1980 | Biochem. Soc. Trans. | pmid:7450249 |
| Wynne TP et al. | Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives. | 1980 | Metab. Clin. Exp. | pmid:7453571 |
| Hirvonen E et al. | Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. | 1981 | N. Engl. J. Med. | pmid:7453723 |
| Abernethy DR and Greenblatt DJ | Impairment of antipyrine metabolism by low-dose oral contraceptive steroids. | 1981 | Clin. Pharmacol. Ther. | pmid:7460468 |
| Ellis EF et al. | Oral contraceptives and cholangiocarcinoma. | 1978 | Lancet | pmid:74629 |
| Barrat J and Durand Chèné F | [Contraception by progestational agents administered in sequential form (author's transl)]. | 1980 | Nouv Presse Med | pmid:7465385 |
| Marr W et al. | The effects of oestrogens and progesterone on oestrogen receptors in female rat liver. | 1980 | Biochem. J. | pmid:7470070 |
| Stanczyk FZ et al. | Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone. | 1980 | Contraception | pmid:7471737 |
| Back DJ et al. | The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. | 1980 | Contraception | pmid:7471739 |
| Bamji MS et al. | Low dose injectable contraceptive norethisterone enanthate 20mg monthly - II. Metabolic side effects. | 1981 | Contraception | pmid:7471743 |
| McGee RR | Hormone therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. | 1995 | South. Med. J. | pmid:7481972 |
| Habiba M et al. | Effect of a new cyclical sequential postmenopausal HRT on lipoprotein, apoprotein and thrombophilia profile. | 1995 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:7493716 |
| Laumas V et al. | Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate. | 1978 | Contraception | pmid:750187 |
| Stanczyk FZ et al. | A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids. | 1978 | Contraception | pmid:750188 |
| Dören M et al. | Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. | 1995 | Am. J. Obstet. Gynecol. | pmid:7503183 |
| Vanin CM et al. | Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate. | 1995 | Am. J. Obstet. Gynecol. | pmid:7503190 |
| Yu H et al. | Oral contraceptive-induced expression of prostate-specific antigen in the female breast. | 1995 | J. Biol. Chem. | pmid:7534765 |
| Meade TW | Effects of low-oestrogen oral contraceptives. | 1978 | Lancet | pmid:75371 |
| Korsan-Bengtsen K and Larsson B | Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol. | 1978 | Gynecol. Obstet. Invest. | pmid:754993 |
| Mück AO et al. | [Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate]. | 1995 | Geburtshilfe Frauenheilkd | pmid:7557206 |
| Gass R and Neff M | [Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate)]. | 1995 | Schweiz Med Wochenschr | pmid:7569830 |
| Wright NM et al. | Estrogen and diclofenac sodium therapy in a prepubertal female with idiopathic juvenile osteoporosis. | 1995 Apr-Jun | J. Pediatr. Endocrinol. Metab. | pmid:7584708 |
| Godsland IF et al. | Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. | 1995 | Contraception | pmid:7587185 |
| Kiilholma P et al. | Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. | 1995 | Fertil. Steril. | pmid:7589632 |
| Sissan MA et al. | Effects of low-dose oral contraceptive oestrogen and progestin on lipid peroxidation in rats. | 1995 Jul-Aug | J. Int. Med. Res. | pmid:7589770 |
| Field B et al. | Inhibition of hepatic drug metabolism by norethindrone. | 1979 | Clin. Pharmacol. Ther. | pmid:759072 |
| Taskinen MR | Postmenopausal hormone replacement therapy and plasma lipoproteins. | 1995 | J. Intern. Med. | pmid:7595177 |
| Proudler AJ et al. | Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. | 1995 | Lancet | pmid:7603219 |
| Tonstad S et al. | Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. | 1995 | J. Intern. Med. | pmid:7608645 |
| Paskowitz RA | "Rollerball" ablation of the endometrium. | 1995 | J Reprod Med | pmid:7608870 |
| Hall GM et al. | Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. | 1995 | Arthritis Rheum. | pmid:7612039 |
| Preston JT et al. | Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. | 1995 | Br J Obstet Gynaecol | pmid:7612535 |
| Oosterbaan HP et al. | The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women. | 1995 | Maturitas | pmid:7616870 |
| Klehr-Bathmann I and Kuhl H | Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate. | 1995 | Maturitas | pmid:7616874 |
| Tamaya T et al. | Local progestational and antiprogestational effects of steroids and their metabolites on the rabbit uterus. | 1979 | Nihon Funin Gakkai Zasshi | pmid:761702 |
| Mainwaring R et al. | Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives. | 1995 | Contraception | pmid:7621683 |
| Datey S et al. | Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research. | 1995 | Contraception | pmid:7621684 |
| Sang GW et al. | A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects. | 1995 | Contraception | pmid:7621685 |
| Sang GW et al. | A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns. | 1995 | Contraception | pmid:7621686 |
| Sitruk-Ware R | Transdermal application of steroid hormones for contraception. | 1995 | J. Steroid Biochem. Mol. Biol. | pmid:7626463 |
| Bassol S et al. | A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives. | 1995 | Contraception | pmid:7628206 |
| Lindgren R et al. | Transdermal hormonal replacement therapy with transdermal progestin every second month. | 1995 | Maturitas | pmid:7666813 |
| Raudaskoski TH et al. | Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device. | 1995 | Maturitas | pmid:7666816 |
| Higashiyama S et al. | [Effects of synthetic sex steroids on the pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) (author's transl)]. | 1976 | Nihon Naibunpi Gakkai Zasshi | pmid:767171 |
| Shyama SK and Abdul Rahiman M | Progestin (norethisterone)-induced genetic damage in mouse bone marrow. | 1993 | Mutat. Res. | pmid:7687021 |
| Ballagh SA et al. | A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol. | 1994 | Contraception | pmid:7705095 |
| Ballagh SA et al. | Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol. | 1994 | Contraception | pmid:7705096 |
| Pasapera AM et al. | Norethisterone metabolites modulate the uteroglobin and progesterone receptor gene expression in prepubertal rabbits. | 1995 | Biol. Reprod. | pmid:7711211 |
| Elkind-Hirsch KE et al. | Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism. | 1995 | Fertil. Steril. | pmid:7720941 |
| Rosselli M et al. | Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. | 1995 | Hypertension | pmid:7721443 |
| Berenson AB and Wiemann CM | Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study. | 1995 | Am. J. Obstet. Gynecol. | pmid:7726249 |
| Weisberg E et al. | The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. | 1995 | Contraception | pmid:7750283 |
| Schlit AF et al. | Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. | 1995 | Contraception | pmid:7750285 |
| Jha P et al. | Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys. | 1995 | Contraception | pmid:7750289 |
| Meuwissen JH et al. | Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy. | 1995 | Maturitas | pmid:7752949 |
| Castro I et al. | Molecular mechanisms of the antihormonal and antiimplantation effects of norethisterone and its A-ring reduced metabolites. | 1995 | Mol. Reprod. Dev. | pmid:7766408 |
| Wermeling DP et al. | Dirithromycin increases ethinyl estradiol clearance without allowing ovulation. | 1995 | Obstet Gynecol | pmid:7784027 |
| De Patre P | [Use of an estro-progestational combination in the treatment of dysfunctional pre-climacteric meno-metrorrhagias]. | 1975 | Minerva Ginecol | pmid:778678 |
| Vecchio TJ | Long-acting injectable contraceptives. | 1976 | Adv Steroid Biochem Pharmacol | pmid:779431 |
| Marslew U et al. | Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use. | 1994 | Maturitas | pmid:7799829 |
| Dericks-Tan JS et al. | Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+. | 1976 | Contraception | pmid:780050 |
| Giner Velázquez J et al. | [Effect of daily oral administration of 0.350 mg of norethindrone on lactation and on the composition of milk]. | 1976 | Ginecol Obstet Mex | pmid:780215 |
| Oropeza MV et al. | Estrogenic actions of norethisterone and its A-ring reduced metabolites. Induction of in vitro uterine sensitivity to serotonin. | 1994 | Arch. Med. Res. | pmid:7803979 |
| von Kesseru E et al. | Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive; final three-year report. | 1994 | Contraception | pmid:7813221 |
| Habiba M and al-Azzawi F | Analysis of menstrual calendars and serum alpha 2-PEG in women on hormone replacement therapy for 12 months. | 1994 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:7821501 |
| Gonzalez P et al. | The use of progestins for programming assisted reproductive cycles and gonadotropin-releasing hormone agonist flare-up protocols in older patients. | 1995 | Fertil. Steril. | pmid:7843425 |
| Vanin CM et al. | The effect of three hormone replacement regimens on bone density in the aged ovariectomized rat. | 1995 | Fertil. Steril. | pmid:7851600 |
| Spellacy WN | Carbohydrate metabolism in male infertility and female fertility-control patients. | 1976 | Fertil. Steril. | pmid:786744 |
| Frenkel Y et al. | Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate. | 1994 | Maturitas | pmid:7877518 |
| Caird LE et al. | Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women. | 1994 | Clin. Endocrinol. (Oxf) | pmid:7889609 |
| Wide L et al. | Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women. | 1995 | Clin. Endocrinol. (Oxf) | pmid:7889633 |
| Surrey ES et al. | Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. | 1995 | Fertil. Steril. | pmid:7890057 |
| Urbanek RW and Cohen DJ | Porphyria cutanea tarda: pregnancy versus estrogen effect. | 1994 | J. Am. Acad. Dermatol. | pmid:7913477 |
| Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction. | 1994 | Contraception | pmid:7924321 | |
| Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction. | 1994 | Contraception | pmid:7924322 | |
| Marsh MS et al. | The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapy. | 1994 | Fertil. Steril. | pmid:7926085 |
| Campagnoli C et al. | Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. | 1994 | Maturitas | pmid:7935029 |
| McGonigle KF et al. | Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy. | 1994 | Gynecol. Oncol. | pmid:7959253 |
| Tepper R et al. | Estrogen replacement in postmenopausal women: are we currently overdosing our patients? | 1994 | Gynecol. Obstet. Invest. | pmid:7959337 |
| Sato N et al. | [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)]. | 1976 | Nihon Naibunpi Gakkai Zasshi | pmid:797581 |
| Tang GP and Chen QQ | [Column switching HPLC method for determination of in vivo release of norethindrone-alpha, beta-poly (3-hydroxypropyl)-DL-asparamide conjugate]. | 1994 | Yao Xue Xue Bao | pmid:7976344 |
| Maiti BR and Hikim AS | The effect of norethisterone (a progesterone-only contraceptive) on the endocrine pancreas of the albino rat. | 1976 | Mikroskopie | pmid:798129 |
| Toppozada MK | Existing once-a-month combined injectable contraceptives. | 1994 | Contraception | pmid:8013216 |
| Seibert B and Günzel P | Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna. | 1994 | Contraception | pmid:8013217 |
| Sang GW | Pharmacodynamic effects of once-a-month combined injectable contraceptives. | 1994 | Contraception | pmid:8013220 |
| Koetsawang S | Once-a-month injectable contraceptives: efficacy and reasons for discontinuation. | 1994 | Contraception | pmid:8013221 |
| Norman-Taylor JQ et al. | Hormone replacement therapy by the transdermal administration of oestradiol and norethisterone. | 1994 | Maturitas | pmid:8015505 |
| Munk-Jensen N et al. | Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial. | 1994 | Am. J. Obstet. Gynecol. | pmid:8030688 |
| Whitcroft SI et al. | Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. | 1994 | Obstet Gynecol | pmid:8041534 |
| Shaw RW | Assessment of medical treatments for menorrhagia. | 1994 | Br J Obstet Gynaecol | pmid:8043556 |
| Giwa-Osagie OF | Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland. | 1994 | Contraception | pmid:8045129 |